Science and Technology: Economy

Debate between Baroness Wheeler and Lord Winston

Thursday 31st October 2024 Lords Chamber

[Lord Winston (Lab)]

My Lords, in 2023, Sir Paul Nurse reported on how best we might keep Britain’s scientific research world-leading. One excellent example he chose to identify in his report was the role of the Medical Research Council’s so-called research units. Sir Paul’s report made it very clear how vital these were and how they must be supported to maintain our scientific expertise in healthcare and so on. These 20 units are scattered around the country and most are associated with universities—Oxford, Cambridge, Dundee, Glasgow, Edinburgh and certainly UCL in London. These units are truly world-class and are recognised worldwide as being absolutely outstanding but threatened. One such is the Cognition and Brain Sciences Unit at Cambridge, which I first visited about 20 years ago and was deeply impressed with what they were doing there. It has an 80-year history of cognition and brain science and its remit includes mental health; it focuses on the current global mental health problems, developmental disorders, stroke, dementia, and the nature of human consciousness.

People at the unit tell me that they do not think they can survive on the funding that is now being offered to them as the MRC has changed its funding plan, as we heard on Monday from my noble friend Lord Vallance when he answered my Question. I am sorry that I have not actually warned him of my speech in advance but, of course, I have been besieged by phone calls all day from different research units across the country that are seriously and deeply concerned about this problem. They think that they cannot survive. The Cognition and Brain Sciences Unit is one of six units in Cambridge that would have to be supported by the university if the MRC ceased the full funding that it currently has. The university has certainly not agreed to fund it—as, indeed, as far as I am aware, no university has agreed to fund any of the host units.

I will refer briefly to another unit that I think is particularly interesting: the Prion Unit in London. That one, of course, is famous for its work on mad cow disease, and how that particular dementia was a result of a protein that could affect the brain and fatally change its other proteins. At a recent meeting in China only a few weeks ago, members of the Prion Unit in London were greeted as the world leaders in this, feted all over, particularly at the main Chinese meeting, and the Chinese are now pouring millions into this research—for what reason I am not sure, but certainly these prions are going to come back. There are lots of species that look as though they could be vulnerable, and certainly the risk of mutation in animal species, perhaps in America, could really recur, and this would produce a massive disaster. The Prion Unit still has a very important role to play.

In answer to my Question on Monday, we heard from my noble friend Lord Vallance, the Minister of State, that the MRC had decided to change the funding model in such a way that the units are now expected to reapply for continued funding for a maximum of 14 years, with a review halfway through, after seven years. It is proposed that the host university funds the principal investigators up to 80% of their salary and the on-costs, and the surviving units will be limited to £3 million per annum. That is quite inadequate to maintain what they are doing: it is probably about one-quarter of what they actually need for their current expenses. Of course, many of these units are lab-based and therefore much more expensive.

I listened to my noble friend Lord Vallance very carefully on Monday when he answered my Question. I was extremely grateful for his care in taking up so much of his time to explain the current position, and also for speaking to me outside the Chamber on various occasions. Ultimately, I do not think that the format of an Oral Question could possibly give him anything like enough time or scope to address the concerns that the scientific community and the employees have about these units. They are certainly worried about their jobs: it is likely to affect up to 200 professors, perhaps, and around 2,100 scientists, which is of major concern.

Of course, my noble friend Lord Vallance was absolutely right to express the need for response-mode funding as an alternative but, unfortunately, as Paul Nurse pointed out, these units are truly unique in so many ways and losing their research output, training and maintaining of technical expertise will be extremely serious. Does my noble friend the Minister accept that the way the research councils have been set up means that we cannot interfere with their decisions on money? But we should indeed have some consciousness about their strategy and this is certainly where politicians have a right to decide. Of course, we all hope that my noble friend the Minister might find a better solution to a crisis which is adversely affecting UK science and those who contribute most effectively towards its success and its continued financial income.

[Baroness Wheeler (Lab)]

My Lords, I respectfully remind noble Lords that the speaking time limit is four minutes. I urge all noble Lords to keep within that so that the debate may be concluded within the time allowed without the Minister having to cut short his response.

Health and Social Care Bill

Debate between Baroness Wheeler and Lord Winston

Monday 27th February 2012 Lords Chamber

[Lord Winston]

My Lords, I find it very difficult, as I have said before, to accept or support this kind of amendment, but I strongly believe in candour and I totally support what many noble Lords, including my noble friend Lord Turnberg, have said around the House. However, there are major problems with putting this kind of amendment into legislation, which would make it extremely difficult to be reasonable. There would be real risks of serious psychological harm to quite a lot of patients. One of the last things we want to do is to involve patients in a perceived injustice or perceived negligence which turns out to fail miserably in the courts of law. I have seen that as horribly damaging with patients I had in the past when I was a medical practitioner, which I am of course no longer.

The other issue not adequately dealt with in this amendment is that of time. At what stage is it justified no longer to be candid? Should somebody who, let us say, sees something from that same health authority a year or two later, or three or four, still be candid about what they think may have gone wrong, or where they are not absolutely certain that it has gone wrong? There is a colossal difficulty in trying to enforce this. Far better is the idea of having some kind of code of practice, to which I think my noble friend Lord Turnberg referred, which ought to be acceptable to doctors.

When I was a trainee surgeon, we did innumerable partial gastrectomies. We now know that that operation was really mutilating and totally wrong; it actually resulted in many people losing weight and not being able to hold down a proper diet. Subsequently, of course, peptic ulceration could be treated by a simple antibiotic therapy. Now, at what stage does that treatment become established or a gastrectomy become a negligent operation? These are very difficult things to define, and I urge that we should not write this proposal into law in the way that is proposed.

[Baroness Wheeler]

My Lords, we had a long debate on this very important issue of the duty of candour before the Recess, and I do not intend to take up very much of the House’s time on this amendment by responding to the issues that we covered then, or by repeating our views on why we are concerned that the Government’s current proposal for a contractual duty will not address the need for the huge cultural change in the NHS that has to take place in order to ensure openness and honesty when things go wrong in the care and treatment of patients.

Nevertheless, I hope that the Minister will accept the case for regulations on including the duty of candour in commissioning contracts. We on these Benches emphasise our commitment to trying to help to make the contractual duty work. I therefore place it on record that we welcome the Minister’s reassurance during the previous debate that he will come back to the House on the outcome and actions resulting from the current government consultation on the contractual duty. I also hope that he will be magnanimous in the victory that he had before the Recess in the vote rejecting statutory requirement by standing by his assurances on a future review of the effectiveness of the contractual duty, after an appropriate period, and whether its effectiveness is being held back by the lack of statutory provision. My third hope is that the NHS Commissioning Board will issue clear and strong guidance to assist CCGs in this matter, and I look forward to the Minister’s response.